secwatch.observer — SEC 8-K summary
======================================

Issuer:     Allarity Therapeutics, Inc. (ALLR)
CIK:        0001860657
Form:       8-K
Filed at:   2023-03-20T23:59:59+00:00
Accession:  0001213900-23-021463
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 5.03, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Allarity stockholders approve 25x increase in authorized shares and reverse stock split authorization
--------------------------------------------------------------------------------

- Approved increase in authorized shares from 30,500,000 to 750,500,000 and common stock from 30,000,000 to 750,000,000.
- Approved reverse stock split at ratio between 1-for-20 and 1-for-35; Board will determine final ratio.
- Vote results: Share increase: 34,265,983 for, 410,898 against; Reverse split: 34,308,947 for, 361,101 against.
- Certificate of Amendment filed with Delaware Secretary of State on March 20, 2023.
- Reverse stock split authorization may allow company to meet Nasdaq minimum bid price requirements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860657/000121390023021463/0001213900-23-021463-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860657/000121390023021463/ea175532-8k_allarity.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-021463

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer